Acute Urticaria Induced by Systemic Corticosteroids in Patient with Pre-existing Aspirin Exacerbated Respiratory Disease by Imran, Muhammad et al.
KANSAS JOURNAL of  M E D I C I N E
 
Acute Urticaria Induced by Systemic 
Corticosteroids in Patient with Pre-existing 
Aspirin Exacerbated Respiratory Disease
Muhammad Imran, M.D.1,2, Yuriy Zgherea, M.D.1,2, 
Ayesha Irum, MBBS1, Selina Gierer, D.O. 1,2 
University of Kansas Medical Center, Kansas City, KS 
1Department of Internal Medicine
2Division of Allergy, Clinical Immunology, & Rheumatology
INTRODUCTION
 Despite the allergic, inflammatory, and immunologic modu-
lating properties of corticosteroids, acute and delayed hyper-
sensitivity reactions have been reported.1-9 There is increas-
ing data regarding hypersensitivity reactions to systemic 
corticosteroids from these reports. The prevalence of hyper-
sensitivity reactions with topical corticosteroids is 2.9 - 6%10-12 
and less than 1% with inhaled and systemic corticosteroids.1,2,13 
 Delayed hypersensitivity reactions after topical corticoste-
roid use have been reported for decades and they were rec-
ognized as the allergen of the year in 2005 by the American 
Contact Dermatitis Society.14 Acute IgE-mediated hypersen-
sitivity reactions occurring within one hour are characterized 
by urticaria and anaphylaxis; while delayed T-cell mediated 
reactions are characterized by urticaria and maculopapular 
exanthems.14,15 Reactions may occur to the corticosteroid or to 
its allergens, making it difficult to identify the true culprit.15 
 We identified a patient without pre-existing urticaria 
who exhibited hypersensitivity reactions to oral steroids 
(prednisone and methylprednisolone), inhaled corticoste-
roids/long-acting beta agonists (fluticasone/salmeterol and 
budesonide/formoterol), and aspirin which caused acute ur-
ticaria, angioedema, and bronchospasm. Clinicians, particu-
larly emergency room staff, must be aware of the potential 
for hypersensitivity to corticosteroids and consider it in the 
differential diagnosis of a patient who has received corticoste-
roids with subsequent sequelae of a hypersensitivity reaction.
CASE REPORT
 The patient was a 58-year-old female with a history of al-
lergic rhinitis, classic aspirin exacerbated respiratory disease 
(AERD), and drug-induced urticaria for almost three decades. 
Her first prednisone exposure was thirty years prior for an 
asthma exacerbation. Within 12 hours, she developed urticar-
ia and has not used oral steroids since. In 2012, she was giv-
en methylprednisolone for asthma and developed urticaria 
within 12 hours after the initial dose (Figure 1). She was chal-
lenged with prednisone 60 mg, and a similar reaction was ob-
served. Additionally, she had developed urticaria within sev-
eral hours of using fluticasone/salmeterol and budesonide/
formoterol. Interestingly, she has tolerated inhaled flutica-
sone, intranasal fluticasone, and inhaled beta agonists alone, 
making the etiology of this reaction difficult to determine.
 As the patient had AERD, we attempted aspirin desensitiza-
tion, but she developed mild urticaria prior to desensitization 
with a pretreatment protocol of prednisone. The patient was 
brought back for aspirin desensitization without prednisone, 
and over the next six hours had progressive urticaria associated 
with difficulty breathing. Thus, the desensitization was discon-
tinued. Her tryptase level was normal. Given her recurrent im-
mediate and delayed hypersensitivity reactions to systemic and 
inhaled corticosteroids, further diagnostic testing was pursued.
Figure 1. Acute urticaria appeared within 12 hours after taking oral 
prednisone. 
 Skin testing. We used the following medications for test-
ing: prednisolone sodium phosphate oral solution 3 mg/1 
ml (Morton Grove Pharmaceuticals, IL), dexamethasone so-
dium phosphate injection suspension 4 mg/1 ml (APP Phar-
maceuticals, LLC, Schaumburg), methylprednisolone ac-
etate injection suspension 40 mg/1 ml (Novaplus, USA), 
and saline negative control and histamine positive control.
 Skin puncture tests (SPT; Table 1) were performed with each 
of the corticosteroids in 10-fold increasing concentrations (1:100, 
1:10, to undiluted). A wheal ≥ 3 mm larger than the negative 
control (saline) was considered positive. Tests were read at 20 
minutes. Intradermal tests (Table 2) with the same corticoste-
roids were performed in 10-fold increasing concentrations 
(1:100 to 1:10) only if the SPTs were negative. Skin puncture 
tests (SPT; Table 1) were performed with each of the cortico-
steroids in 10-fold increasing concentrations (1:100, 1:10, to 
undiluted). A wheal ≥ 3 mm larger than the negative control 
(saline) was considered positive. Tests were read at 20 minutes. 
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Intradermal tests (Table 2) with the same corticosteroids were 
performed in 10-fold increasing concentrations (1:100 to 1:10) 
only if the SPTs were negative. One volunteer who was known 
to tolerate corticosteroids was used as a control. His skin test-
ing was negative with adequate positive and negative controls, 
verifying these were non-irritating concentrations of steroid.
By traditional skin testing, she was positive to all ste-
roids and should avoid systemic steroids. It was also de-
termined that she would not be able to tolerate aspi-
rin desensitization with corticosteroid premedication.
Table 1. Skin puncture test results. 
REAGENT WHEAL/FLARE (mm) RESULTS
Percutaneous testing
Saline 0/0 Negative
Histamine 5/5 Positive
Prednisolone 3 mg/ml (1:100) 0/0 Negative
Methylprednisolone 
40 mg/ml (1:100) 2/2 Negative 
Dexamethasone 4 mg/ml (1:100) 0/0 Negative
Prednisolone 3 mg/ml (1:10) 0/0 Negative
Methylprednisolone 
40 mg/ml (1:10) 0/0 Negative
Dexamethasone 4 mg/ml (1:10) 2/2 Negative
Prednisolone 3 mg/ml 0/0 Negative
Methylprednisolone 40 mg/ml 4/4 Positive
Dexamethasone 4 mg/ml 4/6 Positive
Table 2. Intradermal test results.
REAGENT WHEAL/FLARE (mm) RESULTS
Zero time 20 minutes after
Saline 7/0 Negative
Prednisolone 
0.03 mg/1 ml (1:100) 5/0
4/0
Negative
Methylprednisolone 
0.4 mg/1 ml (1:100) 5/0
6/9
Negative
Dexamethasone 
0.04 mg/1 ml (1:100) 5/0
7/0
Negative
Orapred 
0.03 mg/1 ml (1:10) 6/0
10/0
Positive
DISCUSSION
Corticosteroids often are referred to as “steroids” and are 
produced synthetically. They are related closely to cortisol, a 
hormone naturally produced from cholesterol within the adre-
nal cortex (Figure 2). Corticosteroids have been used since the 
late 1940s for their anti-inflammatory and immunomodula-
tory effects to treat a wide variety of diseases.16 Despite their 
clinical efficacy, steroids can induce multiple severe adverse 
effects, including hypersensitivity reactions, weight gain, 
agitation, and skin thinning, limiting their long-term use.17
Figure 2. Structural formulas of different steroids.4,7,18
The overall rate of hypersensitivity reactions to corticoste-
roids appears to be low in comparison with their high utiliza-
tion.17 However, these reactions may be under-diagnosed; es-
pecially in cases where corticosteroids are being used to treat 
an ongoing allergic reaction and the reaction to the corticoste-
roid may confound the clinical picture. Risk factors that have 
been described for hypersensitivity reactions to corticosteroids 
include atopy, contact dermatitis, drug allergy, asthma or re-
nal transplant. However, it is not clear if these are truly risk 
factors or represent conditions in which corticosteroid use is 
prevalent and therefore, a higher number of patients have hy-
persensitivity reactions.17 The corticosteroids most frequently 
implicated in hypersensitivity reactions are non-fluorinated, 
such as topical hydrocortisone and budesonide and systemic 
methylprednisolone and hydrocortisone.1,18 In a few cases, the 
reactions can be induced by salts, such as succinate, or rarely 
by diluents such as carboxymethylcellulose or metabisul-
fite.3-5,19 With topical corticosteroids, the reaction can be due to 
other ingredients, such as neomycin or cetyl stearyl alcohol.19
Some authors only found skin test positivity with the topi-
cal corticosteroid,3,4,19 while others20 showed that the corticoste-
roid was responsible for the reaction in a patient who devel-
oped bronchospasm after intravenous methylprednisolone. The 
majority of hypersensitivity reactions to corticosteroids appear 
to be due to Gell and Coombs Type I and Type IV immuno-
logically mediated mechanisms.1-3,6-8,20 Type I (acute) reactions 
classically occur less than one hour after drug administration, 
are mediated by drug-specific IgE antibodies, and typically 
present with urticaria and anaphylaxis. Type IV (delayed) re-
actions are induced by T cells, occur within an interval of 
twenty-four to forty-eight hours, and commonly present with 
urticaria and maculopapular exanthems.2,9,19,20 Our patient had 
evidence of an IgE mediated reaction based on the results of 
the skin testing, utilized for acute hypersensitivity reactions.
Assessment of cross-reactivity to corticosteroids may be 
difficult as most individuals have received corticosteroids 
either topically or systemically at some point in the past.
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In many cases, patients do not remember receiving the corti-
costeroid, nor do they recall the type of corticosteroid they re-
ceived. In those cases, it is difficult to confirm whether the clini-
cal presentation is due to cross-reactivity or prior sensitization.
CONCLUSION
 Hypersensitivity to corticosteroids is recognized more in the 
literature.1,2,19,20 Corticosteroid reactions have important thera-
peutic consequences, given the frequency they are used in the 
treatment of a myriad of disease processes.1,2,19-21 Although rare, 
allergic reactions to corticosteroids exist and an immunological 
mechanism, IgE or T cell dependent, have been established.20,21 
Skin testing, in-vitro testing, patch testing, and drug provoca-
tion tests are useful diagnostic tools to determine sensitivity. 
Patients who notice a new rash or worsening of their skin dis-
ease after using corticosteroids should alert their physicians, 
who should be aware to the possibility of a hypersensitivity 
reaction. Emergency room staff, in particular, must be aware 
of corticosteroid hypersensitivity reactions and take this into 
consideration in a patient who has received corticosteroids.
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